Janssen Launches New Medical Information Tool

TITUSVILLE, N.J., Sept. 27, 2012 /PRNewswire/ -- Janssen Scientific Affairs, LLC today announced the launch of JanssenMD™, a new online scientific resource for U.S. healthcare professionals seeking instant access to current information about Janssen products marketed in the U.S. The web-based application is designed for use on desktops, tablets, and smartphones and can be accessed at www.janssenMD.com.

JanssenMD™ has search functionality that enables clinicians to easily find full prescribing information, clinical trial data, and safety information about Janssen medications. It is among the first medical information websites to offer a self-service model that is accessible through mobile devices.

"JanssenMD™ was created to provide healthcare professionals with the information they need, when, where, and how they need it," said Dr. Norm Rosenthal, Chief Scientific Officer, Janssen Scientific Affairs, LLC.  "This unique digital platform enables us to respond to healthcare professionals' questions with information that is current, accurate, and instantly accessible from any device they are using."

Currently, scientific Information is available for five pharmaceutical products – EDURANT^® (rilpivirine), REMICADE^® (infliximab), STELARA^® (ustekinumab), XARELTO^® (rivaroxaban), and ZYTIGA^® (abiraterone acetate); over time, additional Janssen products will be added to JanssenMD™.   Clicking these product names will link to the Full Prescribing Information for that product.

In addition to product information, JanssenMD™ provides access to Janssen Prescription Assistance Programs and Risk Evaluation and Mitigation (REMS) tools.  

About Janssen Scientific Affairs, LLC.

Janssen Scientific Affairs (JSA) is committed to serving the needs of patients through an unwavering passion for scientific and customer service excellence on behalf of the U.S. Janssen Pharmaceutical Companies of Johnson & Johnson.

Driven by our commitment to patients, healthcare professionals, and caregivers, we strive to work in partnership with all stakeholders to develop sustainable and integrated healthcare solutions on the basis of trust and transparency. Guiding our daily work is a desire to meet our goals of excellence in quality, innovation, safety, and efficacy in order to advance patient care.

Visit www.janssenmedicalinformation.com for more information, or follow us on Twitter at www.twitter.com/JanssenUS, or on YouTube at www.youtube.com/JanssenUS.

SOURCE Janssen Scientific Affairs, LLC